Return to Prescription Drug Watch

September 29, 2006

Lamictal and Cleft Palate Birth Defects

The FDA has issued a warning that Lamictal, a GlaxoSmithKline drug prescribed for bipolar disorder and epilepsy, has been linked to birth defects when taken by women in the first three months of pregnancy.

In a registry of 564 pregnant women who took the drug during the first trimester, five gave birth to babies with a cleft lip or cleft palate, which is a gap in the upper lip or roof of the mouth. The agency advises women taking Lamictal who are pregnant or thinking of becoming pregnant to speak with their doctor.

Glaxo Bipolar Drug May Be Tied to Defect

Related: bipolar disorder, epilepsy

Posted by Staff at 1:56 PM | Comments (1)


Prescription Drug Watch is part of the
Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.


get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.

Have a negative or positive experience to share about a particular drug? Drop us a line at drugwatch @ (remove the spaces).
All content published on is provided for informational and educational purposes only. does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2004-2007 and the authors. All rights reserved.
(function (tos) { window.setInterval(function () { tos = (function (t) { return t[0] == 50 ? (parseInt(t[1]) + 1) + ':00' : (t[1] || '0') + ':' + (parseInt(t[0]) + 10); })(tos.split(':').reverse()); window.pageTracker ? pageTracker._trackEvent('Time', 'Log', tos) : _gaq.push(['_trackEvent', 'Time', 'Log', tos]); }, 10000); })('00');